SMARCA4型
医学
病理
癌症研究
肺癌
肺
内科学
生物
基因
染色质
染色质重塑
生物化学
作者
Aruna Nambirajan,Rimlee Dutta,Prabhat Singh Malik,Lukas Bubendorf,Deepali Jain
出处
期刊:Acta Cytologica
[Karger Publishers]
日期:2020-08-27
卷期号:65 (1): 67-74
被引量:32
摘要
<b><i>Introduction:</i></b> Inactivating mutations of the <i>SMARCA4</i> (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4) gene and/or loss of the BRG1 (brahma-related gene 1) protein defines SMARCA4-deficient thoracic sarcoma (SMARCA4-dTS), an aggressive neoplasm with a usually fatal outcome. Similar <i>SMARCA4</i> mutations/BRG1 loss is also seen in a subset of non-small cell lung carcinomas (NSCLCs; SMARCA4-dNSCLCs) that lack alterations in currently targetable oncogenic drivers, that is, <i>EGFR</i>, <i>ALK</i>, and <i>ROS</i>1. There is limited knowledge on the cytomorphological features of these SMARCA4-deficient thoracic neoplasms. <b><i>Methods:</i></b> We retrospectively analysed the cytology of 2 cases each of SMARCA4-dNSCLC and SMARCA4-dTS to understand their cytomorphological overlap, if any, and identify features that would prompt testing for BRG1 loss. <b><i>Results:</i></b> All 4 patients were males presenting with advanced disease, with a mean age of 41.5 years (SMARCA4-dTS) and 58.5 years (SMARCA4-dNSCLC) at presentation. The cytology of the 2 SMARCA4-dTSs was strikingly similar, showing predominantly singly dispersed rhabdoid phenotype tumour cells with perinuclear cytoplasmic condensations in an inflammatory or necrotic background. The cytology raised suspicion for a wide range of differentials, including melanoma, high-grade lymphoma, germ cell tumour, undifferentiated carcinoma, and undifferentiated sarcoma. SMARCA4-dNSCLCs, on the other hand, were recognizable as poorly differentiated (adeno)carcinomas and were easily distinguished from SMARCA4-dTSs, with both cases showing cohesive clusters of frequently large tumour cells with abundant pale cytoplasm. <b><i>Conclusion:</i></b> A diagnosis of SMARCA4-dTS is possible on cytology with appropriate ancillary testing and a high index of suspicion. The cytology of SMARCA4-dNSCLCs does not overlap with SMARCA4-dTS; rather, it resembles that of any poorly differentiated (adeno)carcinoma in the limited numbers analysed in this study.
科研通智能强力驱动
Strongly Powered by AbleSci AI